The novel approach of tirzepatide peptide represents a major advance in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide788538.theideasblog.com/42496462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment